Behavioral Health Business December 2, 2021
The Autism Impact Fund (AIF), which provides venture capital and private equity capital to emerging autism care companies, announced Wednesday that it has invested in seven growth and early-stage companies.
The total amount of funding provided to the companies by AIF was not disclosed. The companies receiving AIF funding include:
- Axial Therapeutics: A clinical stage biopharmaceutical developer of molecule agents, which are intended to treat a variety of conditions like autism
- BiROSA Technologies: A developer of blood tests intended to diagnose autism spectrum disorder (ASD)
- Floreo VR: A virtual platform that provides a range of behavioral therapies
- Joshin: A telebehavioral provider of specialized care needs such as those for autism
- SpectrumAi: A digital company of applied behavior analysis (ABA)...
Today's Sponsors
Today's Sponsor